Wolff-Parkinson-White (WPW) syndrome is a heart condition where an extra electrical pathway between the upper and lower chambers of the heart causes episodes of abnormally fast heart rate. Most people with WPW live normal lives, but in rare cases, the condition can trigger dangerous heart rhythms. The estimated risk of sudden cardiac death is about 0.25% per year in symptomatic patients, or roughly 3% to 4% over a lifetime.
How the Heart’s Electrical System Goes Wrong
In a normal heart, electrical signals travel from the upper chambers (atria) to the lower chambers (ventricles) through a single gateway called the AV node. The AV node acts as a speed bump, slowing the signal slightly so the ventricles have time to fill with blood before they contract.
In WPW, an extra electrical connection sits between the atria and ventricles, bypassing the AV node entirely. Because this accessory pathway conducts electricity faster than the AV node, the signal reaches the ventricles earlier than it should. This early arrival is called “pre-excitation,” and it’s the root cause of every problem WPW creates. The normal signal still travels through the AV node at the same time, so two electrical impulses effectively compete to activate the ventricles, creating the characteristic pattern doctors see on an ECG.
What WPW Feels Like
Many people with the WPW pattern on their ECG never experience symptoms at all. When symptoms do occur, they typically show up as sudden episodes of a racing heart (palpitations), dizziness, shortness of breath, chest tightness, fatigue, or feeling like you might faint. Some people actually do faint. These episodes can start and stop abruptly, lasting anywhere from seconds to hours.
Common triggers include alcohol, caffeine, nicotine, stimulant drugs, strenuous exercise, and emotional stress. Episodes can also happen completely at random with no identifiable trigger, which can be unsettling.
The Arrhythmias That Cause Trouble
The accessory pathway doesn’t just deliver signals too early. It can also create electrical loops where signals circle continuously between the atria and ventricles, driving the heart rate well above normal. Three main arrhythmias occur in WPW patients. The most common is orthodromic atrioventricular reentrant tachycardia, where the electrical signal travels down through the AV node normally but then loops back up through the accessory pathway, creating a rapid circuit. The second type, antidromic tachycardia, runs the same loop in reverse. Both cause a fast heart rate, typically between 150 and 250 beats per minute, and produce palpitations and dizziness.
The third, atrial fibrillation, is the most dangerous. When the upper chambers fibrillate (quiver chaotically), the accessory pathway can conduct those chaotic signals directly to the ventricles without the AV node’s protective slowing effect. If enough rapid signals get through, the ventricles themselves can begin fibrillating, which is a life-threatening emergency. This is the mechanism behind the rare cases of sudden cardiac death in WPW.
How WPW Is Diagnosed
WPW is often discovered by accident during a routine ECG, sometimes in someone who has never had a single symptom. The ECG shows three telltale signs: a short PR interval (under 0.12 seconds, meaning the signal reaches the ventricles faster than normal), a widened QRS complex (0.12 seconds or longer, meaning the ventricles activate in an unusual pattern), and a “delta wave,” which is a distinctive slurred upstroke at the very beginning of the heartbeat tracing. Together, these findings confirm that an accessory pathway is present and conducting electricity.
Doctors distinguish between a “WPW pattern” (the ECG findings alone, without symptoms) and “WPW syndrome” (the ECG findings plus episodes of fast heart rate). This distinction matters because it affects how aggressively the condition is managed.
Risk Stratification
Not all accessory pathways carry the same level of risk. Some conduct electricity slowly enough that they’re unlikely to ever cause a dangerous arrhythmia. Others can transmit signals so rapidly that they could allow atrial fibrillation to deteriorate into ventricular fibrillation.
To sort out which category a patient falls into, doctors may recommend an electrophysiology (EP) study. This involves threading thin catheters into the heart through a vein and directly measuring how fast the accessory pathway can conduct. The key measurement is how quickly repeated electrical impulses can travel through the pathway. If the pathway can conduct signals with intervals of 250 milliseconds or less between beats, it’s considered high risk. Some centers use an even stricter cutoff of 220 milliseconds. The EP study can also determine whether dangerous arrhythmias are inducible, meaning the pathway is capable of sustaining a rapid, looping rhythm when provoked.
Treatment With Catheter Ablation
The definitive treatment for WPW is catheter ablation, a minimally invasive procedure where a thin catheter is guided to the heart and used to deliver targeted energy (usually radiofrequency heat) to destroy the accessory pathway. Once the pathway is eliminated, the electrical short circuit can no longer form, and the risk of WPW-related arrhythmias drops to near zero.
Success rates are high. Multicenter studies show acute success in 93% to 97% of procedures. In one large series of 558 ablation procedures, 97% successfully eliminated the pathway on the first attempt. The complication rate is low, ranging from about 2.9% to 4.2%. Recurrence, where the pathway recovers and begins conducting again, happens in roughly 8% of patients, and a second procedure usually resolves it. Patients with more than one accessory pathway have a higher chance of recurrence.
For people who experience symptoms only rarely and prefer to avoid a procedure, certain medications can slow conduction through the accessory pathway or the AV node and reduce the frequency of episodes. However, medication manages the symptoms without eliminating the underlying problem, and some drugs commonly used for other heart rhythm issues can actually be dangerous in WPW because they may inadvertently speed conduction through the accessory pathway.
Managing WPW Without Symptoms
The approach to asymptomatic WPW has shifted in recent years. Watchful waiting used to be the standard recommendation for people whose ECG showed the WPW pattern but who had never experienced a fast heart rate. That’s no longer universally accepted, particularly for younger patients and athletes.
The 2024 Heart Rhythm Society Expert Consensus Statement on Arrhythmias in the Athlete recommends considering ablation for all athletes with a WPW pattern on ECG. Notably, the same statement points out that patients with WPW should not be restricted from physical activity simply because of the diagnosis, since sudden cardiac death from WPW can occur during everyday activities, not just during exercise. The reasoning is that if the pathway poses a risk, ablation eliminates it, and activity restrictions alone don’t provide meaningful protection.
For asymptomatic patients who are not athletes, the decision often comes down to the EP study results. If the pathway is found to be low risk (slow conduction, no inducible arrhythmias), ongoing monitoring without ablation remains reasonable. If the pathway shows high-risk properties, ablation is typically recommended regardless of whether symptoms have occurred.